The Online Investor
Drugs & Pharmaceuticals M&A image Drugs & Pharmaceuticals M&A » By The Online Investor Staff, updated Fri., Dec. 3, 5:46 PM Recent mergers and acquisitions in the Drugs & Pharmaceuticals M&A category.

Slide #45. PharMerica Corporation BGS Pharmacy Partners, Inc.

Acquirer: PharMerica Corporation (PMC)
Acquiree: BGS Pharmacy Partners, Inc.
Details: PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, and oncology pharmacy services, today announced that on December 31, 2013 it completed the all-cash acquisition of BGS Pharmacy Partners, Inc. Although financial terms of the transaction were not disclosed, the Company expects the acquisition to be accretive to earnings in 2014.

PharMerica is a pharmacy services company that services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting, and provides an oncology pharmacy. As of Dec 31 2016, Co. had 99 institutional pharmacies, 19 specialty infusion pharmacies, and four specialty oncology pharmacies in 45 states, and operated three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Co.'s main business provides pharmacy services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, and other long-term alternative care settings.

Open the PMC Page at The Online Investor »

Company Name: 
PharMerica Corp
Website: 
www.pharmerica.com
Sector: 
Drugs & Pharmaceuticals
 

Open the PMC Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree PMC Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
25th percentile
(ranked lower than approx. 75% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Drugs & Pharmaceuticals M&A - Slide 45 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2021, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.